Cited by 2,123Cancer, Lipids, and MetabolismLipid metabolism and biosynthesisCancer, Hypoxia, and Metabolism

The DOI matches its Crossref record; 81 of the 82 references it cites were found in a registry or an index.

Cellular Fatty Acid Metabolism and Cancer

Open access

Currie, Erin, Schulze, Almut, Zechner, Rudolf, Walther, Tobias C., Farese, Robert V.·2013·Cell Metabolism

DOI 10.1016/j.cmet.2013.05.017PMC PMC3742569

Open this paper in CoChat — free account Open PDF

Abstract

Cancer cells often have characteristic changes in metabolism. Cellular proliferation, a common feature of all cancers, requires fatty acids for synthesis of membranes and signaling molecules. Here, we provide a view of cancer cell metabolism from a lipid perspective, and we summarize evidence that limiting fatty acid availability can control cancer cell proliferation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2013.05.017

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

On the origin of cancer cells
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Cancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452 · cited 1×
“A better understanding of these metabolic changes has prompted new approaches toward cancer therapy (reviewed in Hsu and Sabatini, 2008; Schulze and Harris, 2012).”
Background
ATP-citrate lyase links cellular metabolism to histone acetylation
Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1164097 · Cited by 2,298
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Nieman, K. M., Kenny, H. A., Penicka, C. V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M. R., Romero, I. L., Carey, M. S., Mills, G. B., Hotamisligil, G. S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2492 · Cited by 2,279
Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791

Flagged first, then by citations

Show all 82 references

1 of the 82 references couldn’t be matched to a known paper.

Sorted by citations

Items 501–600 of 1,000

PPARγ signaling in hepatocarcinogenesis: Mechanistic insights for cellular reprogramming and therapeutic implications
Ishtiaq, S. M., Arshad, M. I., & Khan, J. A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108298 · Cited by 48
Decoding the regulatory roles of non-coding RNAs in cellular metabolism and disease
Zong, Y., Wang, X., Cui, B., Xiong, X., Wu, A., Lin, C., & Zhang, Y. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.04.012 · Cited by 50
Therapeutic strategies targeting AMPK-dependent autophagy in cancer cells
Yuan, W., Fang, W., Zhang, R., Lyu, H., Xiao, S., Guo, D. S., Ali, D. W., Michalak, M., Chen, X., Zhou, C., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119537 · Cited by 53
RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer
Li, Y., Sun, F., Li, C., Mo, H., Zhou, Y., Lv, D., Zhai, J., Qian, H., & Ma, F. (2023) · Military Medical Research · doi:10.1186/s40779-023-00470-y · Cited by 49
A novel CPT1A covalent inhibitor modulates fatty acid oxidation and CPT1A-VDAC1 axis with therapeutic potential for colorectal cancer
Hu, A., Wang, H., Xu, Q., Pan, Y., Jiang, Z., Li, S., Qu, Y., Hu, Y., Wu, H., & Wang, X. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102959 · Cited by 52
Polarity switching mass spectrometry imaging of healthy and cancerous hen ovarian tissue sections by infrared matrix-assisted laser desorption electrospray ionization (IR-MALDESI)
Nazari, M., & Muddiman, D. C. (2015) · The Analyst · doi:10.1039/c5an01513h · Cited by 49
Metabolomic analysis reveals altered metabolic pathways in a rat model of gastric carcinogenesis
Gu, J., Hu, X., Shao, W., Ji, T., Yang, W., Zhuo, H., Jin, Z., Huang, H., Chen, J., Huang, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11049 · Cited by 48
Metformin and caffeic acid regulate metabolic reprogramming in human cervical carcinoma SiHa/HTB-35 cells and augment anticancer activity of Cisplatin via cell cycle regulation
Tyszka‐Czochara, M., Bukowska-Straková, K., & Majka, M. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.05.065 · Cited by 49
Gastric cancer depends on aldehyde dehydrogenase 3A1 for fatty acid oxidation
Lee, J., Kim, S. H., Lee, S., Kang, J. H., Lee, S.-H., Cheong, J., & Kim, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-52814-1 · Cited by 49
The Molecular Mechanism of Metabolic Remodeling in Lung Cancer
Chang, L., Fang, S., & Gu, W. (2020) · Journal of Cancer · doi:10.7150/jca.31406 · Cited by 49
Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem–Like Cells and Reduces Metastases through Effects on Lipid Anabolism
Dattilo, R., Mottini, C., Camera, E., Lamolinara, A., Auslander, N., Doglioni, G., Muscolini, M., Tang, W., Planque, M., Ercolani, C., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-1184 · Cited by 48
Foam Cell Macrophages in Tuberculosis
Agarwal, P., Gordon, S., & Martínez, F. O. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.775326 · Cited by 51
Multi-Omics Analysis of Fatty Acid Metabolism in Thyroid Carcinoma
Lu, J., Zhang, Y., Sun, M., Ding, C., Zhang, L., Kong, Y., Cai, M., Miccoli, P., Ma, C., & Yue, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.737127 · Cited by 48
NF-κB mediated regulation of tumor cell proliferation in hypoxic microenvironment
Rastogi, S., Aldosary, S., Saeedan, A. S., Ansari, M. N., Singh, M., & Kaithwas, G. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1108915 · Cited by 50
FABP4-mediated lipid metabolism promotes TNBC progression and breast cancer stem cell activity
Yu, L., Wei, W., Lv, J., Yu, L., Wang, Z., & Cai, C. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217271 · Cited by 50
Lipid metabolism in homeostasis and disease
Li, Z., Deng, W., Yang, L., Tang, C., Yue, J.-M., Monteiro, O., Baptista‐Hon, D. T., & Li, T. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02357-x · Cited by 58
Association of long-chain acyl-coenzyme A synthetase 5 expression in human breast cancer by estrogen receptor status and its clinical significance
Yen, M., Kan, J., Hsieh, C.-J., Kuo, P., Hou, M., & Hsu, Y. (2017) · Oncology Reports · doi:10.3892/or.2017.5610 · Cited by 48
Oleate but not stearate induces the regulatory phenotype of myeloid suppressor cells
Wu, H., Weidinger, C., Schmidt, F., Keye, J., Friedrich, M., Yerinde, C., Willimsky, G., Qin, Z., Siegmund, B., & Glauben, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-07685-9 · Cited by 48
Epicatechin oligomers longer than trimers have anti-cancer activities, but not the catechin counterparts
Takanashi, K., Suda, M., Matsumoto, K., Ishihara, C., Toda, K., Kawaguchi, K., Senga, S., Kobayashi, N., Ichikawa, M., Katoh, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08059-x · Cited by 48
Vitamin D as a Novel Regulator of Tumor Metabolism: Insights on Potential Mechanisms and Implications for Anti-Cancer Therapy
el Maaty, M. A. A., & Wölfl, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102184 · Cited by 48
AKR1B10 activates diacylglycerol (DAG) second messenger in breast cancer cells
Huang, C., Cao, Z., Ma, J., Shen, Y., Bu, Y., Khoshaba, R., Shi, G., Huang, D. A., Liao, D., Ji, H., et al. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22844 · Cited by 47
Advances in metabolomics of thyroid cancer diagnosis and metabolic regulation
Abooshahab, R., Gholami, M., Sanoie, M., Azizi, F., & Hedayati, M. (2019) · Endocrine · doi:10.1007/s12020-019-01904-1 · Cited by 48
LINE-1 Retrotransposition Promotes the Development and Progression of Lung Squamous Cell Carcinoma by Disrupting the Tumor-Suppressor Gene FGGY
Zhang, R., Zhang, F., Sun, Z., Liu, P., Zhang, X., Ye, Y., Cai, B., Walsh, M. J., Ren, X., Hao, X., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0076 · Cited by 51
Effects of overexpression of ACSL1 gene on the synthesis of unsaturated fatty acids in adipocytes of bovine
Zhao, Z., Abbas Raza, S. H., Tian, H., Shi, B., Luo, Y., Wang, J., Liu, X., Li, S., Bai, Y., & Hu, J. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108648 · Cited by 48
Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer
Ligorio, F., Pellegrini, I., Castagnoli, L., Vingiani, A., Lobefaro, R., Zattarin, E., Santamaria, M., Pupa, S. M., Pruneri, G., de Braud, F., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.04.023 · Cited by 49
Overview: Lipid Metabolism in the Tumor Microenvironment
Ma, K., & Zhang, L. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6785-2_3 · Cited by 47
Lipid Metabolism and Lipidomics Applications in Cancer Research
Pan, M., Qin, C., & Han, X. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6785-2_1 · Cited by 50
Aspirin Targets SIRT1 and AMPK to Induce Senescence of Colorectal Carcinoma Cells
Jung, Y. R., Kim, E. J., Choi, H. J., Park, J.-J., Kim, H.-S., Lee, Y., Park, M., & Lee, M. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.098616 · Cited by 50
Prognostic significance of PLIN1 expression in human breast cancer
Zhou, C., Wang, M., Zhou, L., Zhang, Y., Liu, W., Qin, W., He, R. L., Yang, L., Wang, Y., Chen, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10239 · Cited by 47
Solute Carrier Family 27 Member 4 (SLC27A4) Enhances Cell Growth, Migration, and Invasion in Breast Cancer Cells
Yen, M., Chou, S., Kan, J., Kuo, P., Hou, M., & Hsu, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113434 · Cited by 49
Multiple Myeloma and Fatty Acid Metabolism
Masarwi, M., DeSchiffart, A., Ham, J., & Reagan, M. R. (2019) · JBMR Plus · doi:10.1002/jbm4.10173 · Cited by 43
Inhibition of fatty acid synthesis arrests colorectal neoplasm growth and metastasis: Anti-cancer therapeutical effects of natural cyclopeptide RA-XII
Wang, Y., Guo, D., He, J., Song, L., Chen, H., Zhang, Z., & Tan, N. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.088 · Cited by 48
Obesity and pancreatic cancer: An update of epidemiological evidence and molecular mechanisms
Zhou, B., Wu, D., Liu, H., Du, L., Wang, Y., Xu, J., Qiu, F., Hu, S., & Zhan, H. (2019) · Pancreatology · doi:10.1016/j.pan.2019.08.008 · Cited by 48
Evaluation of ultraviolet photodissociation tandem mass spectrometry for the structural assignment of unsaturated fatty acid double bond positional isomers
Fang, M., Rustam, Y. H., Palmieri, M., Sieber, O. M., & Reid, G. E. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02446-6 · Cited by 47
Beyond the Warburg Effect: N-Myc Contributes to Metabolic Reprogramming in Cancer Cells
Yoshida, G. J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00791 · Cited by 49
MiR-4310 regulates hepatocellular carcinoma growth and metastasis through lipid synthesis
Li, H., Chen, Z., Zhang, Y., Yuan, P., Liu, J., Ding, L., & Ye, Q. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.07.029 · Cited by 46
MYCN and Metabolic Reprogramming in Neuroblastoma
Bansal, M., Gupta, A., & Ding, H. (2022) · Cancers · doi:10.3390/cancers14174113 · Cited by 46
Fatty acids in cancer: Metabolic functions and potential treatment
Du, A., Wang, Z., Huang, T., Xue, S., Jiang, C., Qiu, G., & Yuan, K. (2023) · MedComm – Oncology · doi:10.1002/mog2.25 · Cited by 55
Lipid metabolism and its implications in tumor cell plasticity and drug resistance: what we learned thus far?
Vishwa, R., BharathwajChetty, B., Girisa, S., Aswani, B. S., Alqahtani, M. S., Abbas, M. A. E., Hegde, M., & Kunnumakkara, A. B. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10170-1 · Cited by 49
Lipid droplets in central nervous system and functional profiles of brain cells containing lipid droplets in various diseases
Zhang, L., Zhou, Y., Yang, Z., Jiang, L., Yan, X., Zhu, W., Shen, Y., Wang, B., Li, J., & Song, J. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03334-5 · Cited by 54
p53 attenuates AKT signaling by modulating membrane phospholipid composition
Rueda-Rincón, N., Bloch, K. M., Derua, R., Vyas, R., Harms, A. C., Hankemeier, T., Khan, N. A., Dehairs, J., Bagadi, M., Binda, M. M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4067 · Cited by 48
The LINC01138 interacts with PRMT5 to promote SREBP1-mediated lipid desaturation and cell growth in clear cell renal cell carcinoma
Zhang, X., Wu, J., Wu, C., Chen, W., Lin, R., Zhou, Y., & Huang, X. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.11.036 · Cited by 46
Insights Into SND1 Oncogene Promoter Regulation
Ochoa, B., Chico, Y., & Martínez, M. J. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00606 · Cited by 46
Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC
John, B. A., Naczki, C., Patel, C. M., Ghoneum, A., Qasem, S. A., Salih, Z. T., & Said, N. A. (2019) · Oncogene · doi:10.1038/s41388-019-0728-3 · Cited by 46
Ginsenoside Rh2 reverses cyclophosphamide-induced immune deficiency by regulating fatty acid metabolism
Qian, Y., Huang, R., Li, S., Xie, R., Qian, B., Zhang, Z., Li, L., Wang, B., Tian, C., Yang, J., et al. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.2a0419-117r · Cited by 46
Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer
Lebok, P., von Hassel, A., Meiners, J., Hube‐Magg, C., Simon, R., Höflmayer, D., Hinsch, A., Dum, D., Fraune, C., Göbel, C., et al. (2019) · Aging · doi:10.18632/aging.102287 · Cited by 46
miR‐497‐5p mediates starvation‐induced death in colon cancer cells by targeting acyl‐CoA synthetase‐5 and modulation of lipid metabolism
Gharib, E., Nasrabadi, P. N., & Zali, M. R. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29488 · Cited by 48
Sulforaphane downregulated fatty acid synthase and inhibited microtubule-mediated mitophagy leading to apoptosis
Yan, Y., Zhou, Y., Li, J., Zheng, Z., Hu, Y., Li, L., & Wu, W. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04198-2 · Cited by 48
Determination of Pyruvate Metabolic Fates Modulates Head and Neck Tumorigenesis
Chen, T.-Y., Hsieh, Y.-T., Huang, J.-M., Liu, C., Chuang, L., Huang, P.-C., Kuo, T.-Y., Chia, H.-Y., Chou, C.-Y., Chang, C.-W., et al. (2019) · Neoplasia · doi:10.1016/j.neo.2019.04.007 · Cited by 45
Dedifferentiation of Primary Hepatocytes is Accompanied with Reorganization of Lipid Metabolism Indicated by Altered Molecular Lipid and miRNA Profiles
Kiamehr, M., Heiskanen, L., Laufer, T., Düsterloh, A., Kahraman, M., Käkelä, R., Laaksonen, R., & Aalto‐Setälä, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122910 · Cited by 47
Lipid metabolism of cancer stem cells (Review)
Liu, H., Zhang, Z., Song, L., Gao, J., & Liu, Y. (2022) · Oncology Letters · doi:10.3892/ol.2022.13239 · Cited by 45
Connecting Metabolic Rewiring With Phenotype Switching in Melanoma
Falletta, P., Goding, C. R., & Vivas, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.930250 · Cited by 46
Targeting Mitochondrial Metabolic Reprogramming as a Potential Approach for Cancer Therapy
Zhang, L., Wei, Y., Yuan, S., & Sun, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054954 · Cited by 49
A self‐regulated phototheranostic nanosystem with single wavelength‐triggered energy switching and oxygen supply for multimodal synergistic therapy of bacterial biofilm infections
Wang, C., Lv, S., Sun, Z., Xiao, M., Fu, H., Tian, L., Zhao, X., Shi, L., & Zhu, C. (2024) · Aggregate · doi:10.1002/agt2.587 · Cited by 46
Theoretical framework and emerging challenges of lipid metabolism in cancer
Gu, Q., Wang, Y., Yi, P., & Cheng, C. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.12.002 · Cited by 45
Emerging function of mTORC2 as a core regulator in glioblastoma: metabolic reprogramming and drug resistance.
Wu, S., Bi, J., Cloughesy, T. F., Cavenee, W. K., & Mischel, P. S. (2014) · PubMed · doi:10.7497/j.issn.2095-3941.2014.04.004 · Cited by 44
Adipocytes promote cholangiocarcinoma metastasis through fatty acid binding protein 4
Nie, J., Zhang, J., Wang, L., Lu, L., Qian, Y., An, F., Zhang, S., & Jiao, Y. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0641-y · Cited by 45
A novel fatty acid-binding protein 5-estrogen-related receptor α signaling pathway promotes cell growth and energy metabolism in prostate cancer cells
Senga, S., Kawaguchi, K., Kobayashi, N., Ando, A., & Fujii, H. (2018) · Oncotarget · doi:10.18632/oncotarget.25878 · Cited by 45
Acetaminophen cytotoxicity in HepG2 cells is associated with a decoupling of glycolysis from the TCA cycle, loss of NADPH production, and suppression of anabolism
Behrends, V., Giskeødegård, G. F., Bravo-Santano, N., Letek, M., & Keun, H. C. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2371-0 · Cited by 48
Metabolomics of lung cancer: Analytical platforms and their applications
Noreldeen, H. A. A., Liu, X., & Xu, G. (2019) · Journal of Separation Science · doi:10.1002/jssc.201900736 · Cited by 44
Membrane Transporters for Amino Acids as Players of Cancer Metabolic Rewiring
Scalise, M., Console, L., Rovella, F., Galluccio, M., Pochini, L., & Indiveri, C. (2020) · Cells · doi:10.3390/cells9092028 · Cited by 45
Simultaneously targeting SOAT1 and CPT1A ameliorates hepatocellular carcinoma by disrupting lipid homeostasis
Ren, M., Xu, H., Xia, H., Tang, Q., & Bi, F. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00504-1 · Cited by 45
Spatial transcriptomics reveals gene expression characteristics in invasive micropapillary carcinoma of the breast
Lv, J., Shi, Q., Han, Y., Li, W., Liu, H., Zhang, J., Niu, C., Gao, G., Fu, Y., Zhi, R., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04380-6 · Cited by 46
Lipidomics reveals that sustained SREBP-1-dependent lipogenesis is a key mediator of gefitinib-acquired resistance in EGFR-mutant lung cancer
Xu, C., Zhang, L., Wang, D., Jiang, S., Cao, D., Zhao, Z., Huang, M., & Jin, J. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00744-1 · Cited by 47
Prognostic value of microRNAs in osteosarcoma: a meta-analysis
Kim, Y. H., Goh, T. S., Lee, C., Oh, S. O., Kim, J. I., Jeung, S. H., & Pak, K. (2017) · Oncotarget · doi:10.18632/oncotarget.14429 · Cited by 44
Emerging roles of fatty acid metabolism in cancer and their targeted drug development
An, Q., Lin, R., Wang, D., & Wang, C. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114613 · Cited by 45
CD36 and Its Role in Regulating the Tumor Microenvironment
Liao, X., Yan, S., Li, J., Jiang, C., Huang, S., Liu, S., Zou, X., Zhang, G., Zou, J., & Liu, Q. (2022) · Current Oncology · doi:10.3390/curroncol29110642 · Cited by 47
Stimulated Raman Scattering Imaging Sheds New Light on Lipid Droplet Biology
Jia, H., & Yue, S. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c00038 · Cited by 45
The Role of Tumor Metabolic Reprogramming in Tumor Immunity
Zhang, X., Song, W., Gao, Y., Zhang, Y., Zhao, Y., Hao, S., & Ni, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417422 · Cited by 48
Recent Progress in Anti‐Tumor Nanodrugs Based on Tumor Microenvironment Redox Regulation
Yao, L., Zhu, X., Shan, Y., Zhang, L., Yao, J., & Xiong, H. (2024) · Small · doi:10.1002/smll.202310018 · Cited by 45
Molecular Hydrogen Therapy: Mechanisms, Delivery Methods, Preventive, and Therapeutic Application
Jin, J., Yue, L., Du, M., Geng, F., Gao, X., Zhou, Y., Lu, Q., & Pan, X. (2025) · MedComm · doi:10.1002/mco2.70194 · Cited by 46
ACLY and ACC1 Regulate Hypoxia-Induced Apoptosis by Modulating ETV4 via α-ketoglutarate
Keenan, M. M., Liu, B., Tang, X., Wu, J., Cyr, D. D., Stevens, R. D., Ilkayeva, O., Huang, Z., Tollini, L. A., Murphy, S. K., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005599 · Cited by 43
Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials
Troncone, M. J., Cargnelli, S., Villani, L. A., Isfahanian, N., Broadfield, L. A., Zychla, L., Wright, J., Pond, G. R., Steinberg, G. R., & Tsakiridis, T. K. (2017) · Oncotarget · doi:10.18632/oncotarget.17496 · Cited by 45
KRAB-type zinc-finger proteins PITA and PISA specifically regulate p53-dependent glycolysis and mitochondrial respiration
Wang, S., Peng, Z., Wang, S., Yang, L., Chen, Y., Kong, X., Song, S., Pei, P., Tian, C., Yan, H., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0008-8 · Cited by 45
Lysosomal acid ceramidase ASAH1 controls the transition between invasive and proliferative phenotype in melanoma cells
Leclerc, J., Garandeau, D., Pandiani, C., Gaudel, C., Bille, K., Nottet, N., Garcia, V., Colosetti, P., Pagnotta, S., Bahadoran, P., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0500-0 · Cited by 53
Fatty acid synthase, Her2/neu, and E2F1 as prognostic markers of progression in non-muscle invasive bladder cancer
Abdelrahman, A. E., Rashed, H. E., Elkady, E., Elsebai, E. A., El-Azony, A., & Matar, I. (2019) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2019.01.002 · Cited by 43
Serum Metabolomics Study of Nonsmoking Female Patients with Non-Small Cell Lung Cancer Using Gas Chromatography–Mass Spectrometry
Mu, Y., Zhou, Y., Wang, Y., Li, W., Zhou, L., Lu, X., Gao, P., Gao, M., Zhao, Y., Wang, Q., et al. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00069 · Cited by 44
ROS and Lipid Droplet accumulation induced by high glucose exposure in healthy colon and Colorectal Cancer Stem Cells
Tirinato, L., Pagliari, F., Franco, S. D., Sogne, E., Marafioti, M. G., Jansen, J., Falqui, A., Todaro, M., Candeloro, P., Liberale, C., et al. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.09.010 · Cited by 42
Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum
Penney, K. L., Tyekucheva, S., Rosenthal, J., Elfandy, H., Carelli, R., Borgstein, S., Zadra, G., Fanelli, G. N., Stefanizzi, L., Giunchi, F., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0548 · Cited by 46
Tumor microenvironment metabolites directing T cell differentiation and function
Liu, X., Hoft, D. F., & Peng, G. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.12.004 · Cited by 45
Metformin Accumulation Correlates with Organic Cation Transporter 2 Protein Expression and Predicts Mammary Tumor Regression In Vivo
Checkley, L. A., Rudolph, M. C., Wellberg, E. A., Giles, E. D., Wahdan-Alaswad, R. S., Houck, J. A., Edgerton, S. M., Thor, A. D., Schedin, P., Anderson, S. M., et al. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0211-t · Cited by 43
CPT1A and fatty acid β-oxidation are essential for tumor cell growth and survival in hormone receptor-positive breast cancer
Jariwala, N. H., Mehta, G. A., Bhatt, V. D., Hussein, S., Parker, K. A., Yunus, N., Parker, J. S., Guo, J. Y., & Gatza, M. L. (2021) · NAR Cancer · doi:10.1093/narcan/zcab035 · Cited by 46
Renal Cell Cancer and Obesity
Gluba-Brzózka, A., Rysz, J., Ławiński, J., & Franczyk, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063404 · Cited by 45
Selenium Nanoparticles (SeNPs) Immunomodulation Is More Than Redox Improvement: Serum Proteomics and Transcriptomic Analyses
Xia, I. F., Kong, H.-K., Wu, M. M., Lu, Y.-S., Wong, K.-H., & Kwok, K. W. H. (2022) · Antioxidants · doi:10.3390/antiox11050964 · Cited by 41
Adding fuel to the fire: The lipid droplet and its associated proteins in cancer progression
Luo, W., Wang, H., Ren, L., Lu, Z., Zheng, Q., Ding, L., Xie, H., Wang, R., Yu, C., Lin, Y., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.74902 · Cited by 44
Fatty acid metabolism-related enzymes in colorectal cancer metastasis: from biological function to molecular mechanism
Li, B., Mi, J., & Yuan, Q. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02126-9 · Cited by 50
Peroxiredoxin 6 triggers melanoma cell growth by increasing arachidonic acid-dependent lipid signalling
Schmitt, A., Schmitz, W., Hufnagel, A., Schartl, M., & Meierjohann, S. (2015) · Biochemical Journal · doi:10.1042/bj20141204 · Cited by 45
Bruton's tyrosine kinase is a potential therapeutic target in prostate cancer
Kokabee, L., Wang, X., Sevinsky, C. J., Wang, W. L. W., Cheu, L. A., Chittur, S. V., Karimipoor, M., Tenniswood, M., & Conklin, D. S. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1078023 · Cited by 43
Link between obesity and cancer: role of triglyceride/free fatty acid cycling.
Gong, Y., Lj, D., & Liang, J. (2014) · PubMed · Cited by 43
Thyroid follicular adenomas and carcinomas: molecular profiling provides evidence for a continuous evolution
Dom, G., Frank, S. K., Floor, S. L., Kehagias, P., Libert, F., Hoang, C., Andry, G., Spinette, A., Craciun, L., Aubin, N. D. S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23130 · Cited by 43
Role of AMPK and its molecular intermediates in subjugating cancer survival mechanism
Thirupathi, A., & Chang, Y. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.04.039 · Cited by 43
Analytical challenges of shotgun lipidomics at different resolution of measurements
Wang, J., & Han, X. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.115697 · Cited by 42
Prolyl isomerase Pin1 in metabolic reprogramming of cancer cells
Nakatsu, Y., Yamamotoya, T., Ueda, K., Ono, H., Inoue, M.-K., Matsunaga, Y., Kushiyama, A., Sakoda, H., Fujishiro, M., Matsubara, A., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.10.043 · Cited by 43
Loss of HMGCS2 Enhances Lipogenesis and Attenuates the Protective Effect of the Ketogenic Diet in Liver Cancer
Wang, Y.-H., Suk, F., & Liao, Y. (2020) · Cancers · doi:10.3390/cancers12071797 · Cited by 44
RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4
Wang, C., Chen, Z., Yi, Y., Ding, Y., Xu, F., Kang, H., Lin, K., Shu, X., Zhong, Z., Zhang, Z., et al. (2024) · Oncogene · doi:10.1038/s41388-023-02902-4 · Cited by 42
Fatty acids metabolism affects the therapeutic effect of anti-PD-1/PD-L1 in tumor immune microenvironment in clear cell renal cell carcinoma
Lin, H., Fu, L., Li, P., Zhu, J., Xu, Q., Wang, Y., Mumin, M. A., Zhou, X., Chen, Y., Shu, G., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04161-z · Cited by 42
The activated CD36-Src axis promotes lung adenocarcinoma cell proliferation and actin remodeling-involved metastasis in high-fat environment
Liu, L., Wang, B., Zhang, R., Wu, Z., Huang, Y., Zhang, X., Zhou, J., Yi, J., Shen, J. X., Li, M., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06078-3 · Cited by 48
Nanomedicines Targeting Metabolic Pathways in the Tumor Microenvironment: Future Perspectives and the Role of AI
Fan, S., Wang, W., Che, W., Xu, Y., Jin, C., Dong, L., & Xia, Q. (2025) · Metabolites · doi:10.3390/metabo15030201 · Cited by 43
Noncoding RNAs in Regulation of Cancer Metabolic Reprogramming
Yang, D., Sun, L., Li, Z., & Gao, P. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-1498-7_7 · Cited by 42
DHRS2 mediates cell growth inhibition induced by Trichothecin in nasopharyngeal carcinoma
Luo, X., Li, N., Zhao, X., Liao, C., Ye, R., Cheng, C., Xu, Z., Quan, J., Liu, J., & Cao, Y. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1301-1 · Cited by 42

Authors: Currie, E., Schulze, A., Zechner, R., Walther, T. C., & Farese, R. V.
Affiliations: University of California, San Francisco (US)
Cancer Research UK (GB)
University of Graz (AT)
Yale University (US)
Corresponding author: Farese, Robert V.
ORCID: Schulze, Almut
Zechner, Rudolf
Walther, Tobias C.
Farese, Robert V.
Venue: Cell Metabolism
Publisher: Elsevier BV
Published: 2013-08
Volume: 18
Issue: 2
Pages: 153-161
ISSN: 1550-4131 (ISSN-L)
DOI: 10.1016/j.cmet.2013.05.017
PMC: PMC3742569
OpenAlex: W1980568044
Cited by: 2,123
References: 82
Citations by year: 2026: 118 · 2025: 221 · 2024: 228 · 2023: 221 · 2022: 266 · 2021: 204 · 2020: 193 · 2019: 177 · 2018: 139 · 2017: 122 · 2016: 115 · 2015: 72 · 2014: 41 · 2013: 1
FWCI: 6.32
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 370 d)
doi.org/10.15223/policy-017 (stm-asf)
doi.org/10.15223/policy-037 (stm-asf)
doi.org/10.15223/policy-012 (stm-asf)
doi.org/10.15223/policy-029 (stm-asf)
doi.org/10.15223/policy-004 (stm-asf)
Locations: Cell Metabolism (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of General Medical Sciences (R01GM099844, R01GM097194)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK056084, P30DK063720, P30DK026743)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords: fatty acid metabolism, cancer metabolism, lipid metabolism, tumor cell proliferation, fatty acid availability, membrane lipid synthesis
MeSH terms: Energy Metabolism, Fatty Acids, Humans, Neoplasms, Cell Proliferation, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cellular Fatty Acid Metabolism and Cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks